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CHAPTER· I 
INTRODUCTION 
'l'his thesis reports st1,1dies of three-different mammalian enzymes, 
lactate dehydrogenase (LDH), glutamate dehydrogenase (GDH), and 
glyceraldehyde-3-phosphate dehydrogenase (G3PD), These projects are 
part of investigations of the catalytic and regulatory properties of 
these enzymes at physiological concentrations (0,2 - 2 mg enzyme/ml) 
which were in progress in our laboratory. Th~· relation of this thesis 
to the overall investigations is described in detail·in the separate 
sections devoted to each enzyme. 
An aspect of enzyme regulation which has not.been explored until 
recently is the occurrence.in vivo of many enzymes at concentrations 
about. 103 times th9se ~onventionally used to determine enzyme kinetic 
properties (1). Several such enzymes exist at substrate concentrations 
and possess sufficient binding capacity to-bind a significant amount of 
their substrates. Enzymes at high concentration are subject.to increased 
protein-protein interactions and as a consequence, it is reasonable to 
expect the distribution of different,molecular weight species will be 
shifted in the direction of higher states of association. It is also 
possible that higher molecular weight forms exhibit kinetic and ligand 
binding constants different from lower.molecular weight species. Thus, 
regulatory properties of physiological concentrations of enzymes may 
differ markedly from regulatory properties determined at diiute enzyme 
1 
concentrations •. Extrapolation from results in vitro to metabolic con-
sequences in~ cannot be made with confidence. A better understand-
ing of.metabolic regulation should be based on data at cellular enzyme 
concentrations~ however. 
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CHAPTER II 
A BRIEF INTRODUCTION TO THE ENZYMES 
LDH 
In the last step of anaerobic glycolysis, lacti~ acid dehydrogenase 
(E.C.1.1.1.27) catalyzes the reduction of pyruvate tq lactate 
Pyruvic Acid+ NADH + H+-;--' Lactic Acid+ NAD+ 
The-overall equilibrium of this reactio~ lies far to the right and has 
a large negative value of ~Go~. 
When muscle cells of higher organisms functi9n anaerobically during 
short bursts of strenuous activity, this reaction is utilized by the 
cell to reoxidize NADH to NAD which is needed for the oxidative phos-
phorylation ot glyceraldehyde-3-phos~hate. The coupled relationship 
between the~e two redox reactions provides a continued regeneration of 
NAD, present in limited quantities compared witq the:carbohydrate supply, 
and thus permits skeletal muscle to continue fupctioning during periods 
of limited oxygen.supply. 
Unlike the phosphorylated intermediates of glycolysis, lactate and 
pyruvate may diffuse-across the cellular plasma membrane. Thus lactate 
does.not accumulate during anaerobic glycolysis, but is carried by the 
circulatory system to the heart or to the liver. In these tissues, which 
function under aerobic conditions, pyruvate is oxidized to acetyl CoA, 
which enters the Krebs cycle, or in liver may be utilized in part for 
3 
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gluconeogenesis. Under aerobic conditions, NADH from.the oxidative 
phosphorylation of glyceraldehyde-3-phosphate·is reoxidized to NAD by 
the mitochondrial electron transport system via the glycerol phosphate 
or malate shuttle instead of the LDH reaction. Thus, while LDH permits 
anaerobic glycolysis and generation of ATP (2 moles ATP/mole glucose), 
aerobic oxidation of pyruvate is much more efficient. (36 moles ATP/mole 
glucose) since it not only allows complete oxidation of pyruvate; but 
also involves the mitochondrial electron transport system. 
In mammals and birds there are 5 LDH isozymes with essentially the 
same molecular weight which catalyze the same reaction, but with dif~ 
ferent kinetic and ligand binding constants. The enzymes are tetramers 
of a or B subunits; the isozymes.correspond to the 5 different permuta-
tions of.the two subunits within the tetramer. The isozyme predominating 
in heart tissue.is an a tetramer designated as LDH-1 (formerly labeled 
H4 or H~LDH) and is characterized by inhibition of its activity by high 
concentrations of pyruvate. 
The isozyme.found predominantly in skeletal muscle and liver is 
designated as LDH-5, ( a s4 tetramer) and is much less sensitive to 
pyruvate inhibition. In both cases, pyruvate·inhibition is thought to 
be the result of a pyruvate-NAD-enzyme dead-end complex; the equilibrium 
for complex formation with heart isozyme was presumed higher than with 
muscle isozyme. As a result of the higper sensitivity of the heart 
isc;>zyme to substrate inhibition by pyruvate, and related properties 
Kaplan (2) has proposed that LDH-5 functions essentially as a pyruvate 
reductase; whereas, LDH-1 is primarily involved in dehydrogenation of 
• 
lactate, This situation would allow pyruvate to be oxidized by the Krebs 
cycle in aerobic tissue such as heart and thus would be more 
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energetically favorable for aerobic tissue than reduction of pyruvate to 
lactate. Griffin and Criddle. (3) have recently desc;ribed marked enzyme 
concentration dependence,of kinetics and equilibria for formation of 
thepyruvate..,.NAD-enzyme dead-end complex with. the muscle isozyme. Data 
are lacking, however, on the heart isozyme which according .to Kaplan's 
theory is the only LDH isozyme.appreciably affected by this complex in 
.-
vivo, Another defici·ency in· available data is that Kaplan's (4) latest. 
measurements, from which they greatly extend their. original theories, 
are confined to chicken enzymes, although chemical differences have been 
claimed between chicken and mammalian heart enzymes (5), 
Wuntch et al, (6) have objected to Kaplan's view of LDH isozyme 
function and. present data which indicate that substrate· inhibition of 
LDH-1 and LDH-5 by maximum physiological concentrations of pyruvate 
~ 0.8 mM in skeletal muscle) does not occur at physiological enzyme 
concentrations. However, at dilute, unphysiological enzyme concentra-
tions, the activity was severely inhibited. Wu~tch et al. concluded 
that pyruvate inhibition of LDH is probably not physiologically signifi-
cant. The original conclusions.of Wuntch et al. (7) have been questioned 
since their,measurements probably corresponded to an.unphysiological 
transient conditon prior to formation of the pyruvate-NAD-enzyme dead-
end complex. Wuntch et al. (8) replied with additional data, but their 
reasoning is questionable and experimental design inadequate; their 
conclusions regarding the.extent of inhibition when LDH is incubated 
with pyruvate and NAD do not appear to us to be supported by their own 
data, for example. 
Stambaugh and Post, (9) have presented data on substrate and product 
inhibitions of LDH by lactate and pyruvate from which they have concluded 
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that lactate exerts the more·significant influence on LDH in vivo. 
However, their data are too limited to confidently extrapolate to physi-
ological levels of pyruvate and lactate and were confined to enzyme 
concentrations less than 1 µg/ml. In addition, these.data must.be re-
investtgated in light.of the slowness of dead-end complex formation (3). 
Most. studies have not initiated the catalytic reaction from equilibrium 
with respect to dead-end complex formation even though it may be assumed 
that the simultaneous presence·in vivo of both pyruvate and NAD would 
produce considerable dead-end complex. 
Due to conflicting viewpoints and lack of data, we have attempted 
to characterize the properties of LDH with physiological ranges of sub-
strates, products and enzyme conc~ntrations at both.25 and 37°. As 
part of this project, this thesis reports measurements characterizing 
pyruvate product inhibition of LDH-catalyzed lactate oxidation, Other 
measurements from our laboratory on LDH are reported in a manuscript in 
preparation. 
GDH 
Bovine liver.glutamate dehyclrogenase (E.C.1.4.1.3) catalyzes the 
following reaction: 
+ + H20 +Glutamate+ NAD(P) ~a-KG+ NAD(P)H + H +·NH3 
The reaction is particularly important for all species since it is es-
sentially the only pathway for the formation of a-amino acids directly 
from NH3 • Thus, GDH provides a link between amino acid and carbohydrate 
metabolism in animal tissues. This reaction also fulfills an important 
function in the regulation of ammoniµm ion concentration in liver. 
Toxic concentrations of ammonium ion may be disposed of by three methods: 
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(a) by direct.excretion of ammonium ion, or (b) by utilizing the reverse 
direction of the above reaction as part of a salvage pathway for amino 
acid biosynthesis, or (c) it may be mobilized by various transaminations 
into glutamate, which provides NH3 for urea synthesis via its GDH-
catalyzed oxidative deamination •. Rapid and extensive reversal of path-
way (c) is toxic in that the equilibrium positio~ of the GDH-catalyzed 
reaction strongly favors reductive aminatton of a-ketoglutarate. This 
can quite effectively remove a-KG from the Krebs cycle in the absence 
of compensating anaplerotic reactions, resulting in inhibition of res-
piration, as well as excess ketone body formation from acetyl CoA in 
liver. Thus, the concentration of ammonium ion in liver is carefully 
regulated by GDH and the urea cycle. 
The enzymatically active monomer of GDH which predominates at 
concentrations below 10 µg/ml has a molecular weight of 313,000 daltons 
(10) and is composed of six apparently identical subunits of molecular 
weight 52,000. Further dissociation requires denaturing agents and is 
largely irreversible. The enzyme monomer (a hexamer of subunits) under-
goes self-association with increasing enzyme concentration in vitro above 
0.1 mg/ml forming long, linear oligomers of increasing size (10). The 
concentration of the enzyme in liver mitochondria is considered to be in 
excess of 2 mg/ml. 
Spivey (11) has reported previously that when GDH concentration in 
vitro is increased to greater than 0.75 mg/ml substrate inhibitions by 
NADH and a-ketoglutarate are entirely abolished; inhibitiqns by the 
hormones progesterone., thyroxine, estradiol and its analog diethylstil-
bestrol, which are effective at µM levels of dilute enzyme are greatly 
reduced, as is inhibition by the allosteric modifier, GDP (12). In 
8 
contrast to the altered inhibitions,·activation by the allosteric 
modifiers ADP and ATP as well as kinetic parameters determined with sat-
urating levels of substrate$ and no inhibitors are·not affected by in-
creasing enzyme concentration. above·0.75 mg/ml (l3), 
If the concentrations of reactants and modifiers of an enzyme are 
sufficiently greater than the enzyme concentration even when the reaction 
is studied at high enzyme-concentration (1 mg/ml• 20 µMin GDH bipding 
sites) then there exist only two mechanisms by which the enzymic.reaction 
rates could significantly differ between dilute and concentrated enzyme 
solutions. The first mechanism is through a hysteretic transition (e,g., 
a slow response to a rapid change in ligand concentration) in an enzyme 
form such that at the lower enzyme concentrations and slower catalytic 
turnover, only the catalysis with transformed enzyme is observed. With 
higher enzyme concentrations, however, only untransformed enzyme exists 
during the observed initial velocity period because of the slowness of 
transformation relative to. catalytic turnover, The second mechanism for 
obtaining enzyme~dependent. specific activities requires an enzyme asso-
ciation-dissociation equilibrium. It is necessary to distinguish between 
these two mechanisms to evaluate the physiological significance, if any, 
of observed ch~nges in enzyme activities with enzyme concentration. 
If the hysteretic transition occurs from an.enzyme form other than 
the central enzyme complex, incubation of enzyme with the appropriate 
combination of substrates and products prior to initiating the catalytic 
reaction should eliminate or grossly alter transitions during the c~ta-
lytic reaction.· Incubation of LDH with NAD and pyruvate permits the 
hysteretic transition to the ternary dead-end complex to occur, for 
example~ Catalytic reaction rates observed after subsequent addition of 
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NADH to the concentrated LDH reaction.mixtures are therefore extensively 
inhibited, Substrate inhibition of concentrated LDH by pyruvate will 
not be apparent without the pre~incubation; that.is, pre-incubation of 
LDHwith NAD and pyruvate restores the substrate inhibitiQn observed with 
dilute.LDH. 
It was not possible to restore NADH and GDP inhibition of concentra-
ted GDH by any possible permutation of incubations, including products 
with substrates which might form dead-end complexes, except possibly 
with an equilibrium mixture of substrates and products, which has not 
yet been tried (14). A hysteretic transition from a central enzyme com-
plex or enzyme association therefore remained as possible reasons for the 
loss of substrate inhibition at high enzyme concentrations. A transition 
from uninhibited to inhibited enzyme had always been observed within the 
expected initial velocity extent of reaction with 0.2 - 0.3 mg enzyme/ml 
in support of a hysteretic transition. Evidence on the effects of enzyme 
association on the substrate inhibitton, however, were lacking. The 
recent report that saturation of buffers with toluene or benzene greatly 
enhances GDH association, without, affecting its specific activity, pro-
vided us with a direct and potentially conclusive method for correlating 
changes in enzyme inhibition with extents of enzyme association (15). 
These measurements were therefore made as part of this thesis as des-
cribed in the following chapter. 
G3PD 
D-glyceraldehyde-3-phosphate:NAD oxidoreductase. (phosphorylating) 
(E.C.1.2-1.12) catalyzes the oxidation and phosphorylation of the C-1 
aldehyde of D-glyceraldehyde-3-phosphate to give 1,3-diphosphoglycerate, 
a. mixed anhydride of a carboxylic acid and orthophosphoric acid, The 
reducing equivalents are transferred from D-G3P to the B side of the 
nicotinamide ring of NAD. 
The enzyme is a tetramer of molecular weight 145,000·and is con-
sidered to have· four subunits, each of molecular weight.36,000. The 
enzyme contains sulfhydryl groups necessary for enzymatic activity and 
14 of these are titratable. Four of the sulfhydryls are particularly 
reactive and are located at the active site of each subunit. 
Conflicting claims have been made for the steady-state mechanism 
lO 
of G3PD. Furfine and Velitk (16) had concluded from equilibria of 
partial reactions and from extensive steady-state kinetic studies of the 
rabbit muscle enzyme that random addition and release of substrates and 
products best describes the kinetic mechanism. These authors also re~ 
port that the rate-limiting step occurs in the reaction of a kinetically 
important quaternary enzyme-substrates complex, namely, acyl group trans-
fer from the enzyme to an external acceptor. Orsi and Cleland (17) have 
criticized these conclusions and presented data which they claim are 
compatible only with an ordered ter-bi reaction, with NAD, aldehyde and 
phosphate or.arsenate adding in this order. Release of acid precedes 
the rate-limiting step, NADH release, in their proposed mechanism. 
Stopped-flow data from Trentham's lab (18) on the lobster enzyme 
and from our lab on the rabbit.muscle enzyme suggest a reason for the 
conflicting views. The· rates of NADH release from enzyme-NA.DH complex 
are essentially independent of pH. At.low pH, rates of catalytic turn-
over are less than rates of NADH release, but increase with pH and 
exceed the rates of NADH release at pH values greater than 7.8. Thus, 
the NADH release step becomes rate-limiting only at pH values above 7.8 
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and an alternative pathway may be used at lower pH values. A similar 
shift in mechanism has been reported for aldose reductase (19). Orsi 
and Cleland's data were confined to pH 8.6 and the data of Furfine and 
Velick which appear in conflict with the ordered mechanism were confined 
to pH 7.4. Clarification of the mechanism is of importance for two 
reasons. First, to assi~t in the interpretation of some of our stopped-
flow data, we need to know whether NADH can be released from acylated 
enzyme which is produced by NAD oxidation of D-G3P in the absence or 
acyl acceptor (20). The ordered mechanism claimed by Orsi and Cleland 
would not permit this. In a wider context, however, it would be of 
interest to know to what extent an apparent ordered mechanism is but a 
special case of random pathways;.depending on pH and other factors 
(alternate substrate; modifiers, etc.), Steady-state kinetic measure-
ments designed to help answer this question are reported in Chapter III. 
CHAPTER III 
MATERiALS AND-EXPERIMENTAL PROCEDURES 
~aterials 
Rabbit. muscle and beef heart lactic acid dehydrogenases were 
obtained as the ammonium sulfate suspensions from Sigma Chemical Company, 
(types II and III, respectively). Disc-gel.electrbphoresis of the heart 
isozyme, and further purification by preparative polyacrylamide electro-
phoresis had not,altered it:s kinetic properties (21). The enzymes were 
therefore µsed without further purification. Also obtained from Sigma 
were the lithium salt of 1.,..(+)-lactic acid, imidazole (Grade III, low 
fluorescence blank), bicine and dithiothreitol. DL-G3P was obtained 
from Sigma, either as the free acid, or prepared from its diethylace~al 
according to the procedure of Furfine and Velick (16). Ammonium sulfate 
suspensions of bovine liver glutamate dehydrogenase and rabbit muscle 
glyceraldehyde.-3-phosphate dehydrogenase were purchased from Boehringer-
Mannheim Corporation. G3PD was also obtained from the white skeletal 
muscle of the legs and spine of·New Zealand White rabbits according to 
a ~rocedure by Ferdinand (22). This latter source of G3PD was from a 
preparation of Dr. B. C. Peczon in our laboratory. The product, 1,3-
diphosphoglyceric acid used for product inhibition studies of G3PD was 
prepared by oxidative phosphorylation of G3P using the procedure of 
Negelein (23) as modified by Furfine and Velick (16). The sodium salt 
of pyruyic acid and a-ketoglutaric acid were obtained from Calbiochem; 
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NAD (free acid) and disodium NADH, both Chromatopure grade, were 
purchased from p.;.1 Biochemicals, - DisG>dium EDTA was obtained from 
Schwarz-Mann, and glutaric acid was ·.t,t.irchased from Eastman Organic 
Chemicals. K2HP04 , KH2Po4 , NaCl, NH4c1) benzene, triethanolamine, 
Na4P207, KCl and Na2P04, all reagent grade, were obtained from Fisher. 
Na2HAso4 was supplied by Mathieson, Coleman and Bell, Benzene was dis-
tilled prior to use. and only the fraction collecti_on at 59° C was used, 
Solutio-r.t Preparations 
Potassium phosphate buffer, 0.05 M, pH 7.5, containing 0.2 M NaCl, 
-4 and lxlO M EDTA, was- prepared from stock solutions of 0.2 M potassium 
dihydrogen phosphate and 0.2 M dipotassium hydrogen phosphate. Enzyme 
and reagent. stock solutions used in all LDH measurements and some GDH 
measurements were.prepared in this puffer, Saturation of phosphate 
buffer with benzene for use in other GDH measurements was accomplished 
by adding an excess of the amount of benzene needed to saturate the buf-
fer and stirring vigorously for 24 hours at room temperature prior to 
use (15). Enzyme and reagent stock solut_ions used in G3PD kinetic 
measurements performed at pH 6.0 and pH 8.6 were prepared in imidazole 
buffer, 0.05 M, pH 6.0, which contained 0.1 M KCl, lxlo-3 M EDTA, and 
lxio-3 M dithiothreitol, or in bicine-acetate buffer, 0.02 M, pH 8.6, 
which contained 5xlo-4 M EDTA. Enzyme, substrate and coenzyme stock 
solutions used in a standard assay (Table I) of G3PD activity were pre-
pared in triethanolamine buffer 0,04 M, pH 8.7, which contained 0.05 M 
Na2HP04 and 2x10 .. 4 M EDTA (22). Nucleotide coenzyme stock solutions 
were prepared fresh daily. The purity of NAD was determined prior to 
its first use and was not assayed again (24). Concentrations of NADH 
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TABLE I 
ENZYME STANDARD ASSAY CONDITIONS 
LDH GDH G3PD 
Buffer KP04, 0,05 M, = N(CH2CH20H)3, KPOf O .05 M, 
pH 7.5, NaCl, pH .5, NaCl, 
0.2 M, EDTA, 0.2 M, EDTA, 0.04 M, pH 8.7 
0.1 mM 0.1.mM 
Substrates 
and their Lactate, NH4Cl, 0.1 M G3P, 20 mM 
concentra- 1.5 mM ct-KG, 5 mM Na2HP04, 0.5 M 
tion 
Co enzymes 
and their NAD, 1 mM NADH, 0.15 mM NAD, 0.83 mM 
concentra-
tion 
Enzyme 
concentra- 0.2~0.4µg/ml 0.5 µg/ml 0.17 µg/ml 
tion 
Specific 
Activity 100 units/mg 60 units/mg 130 units/mg 
Obtain~d 
15 
stock solutions were verified by measuring UV absorbance·at 340 nm. The 
pH of-,?11 reagent stock solutions was adjusted to the desired value with 
\ 
KOH or HCl, if necessary. All pH measurements were.made with a Fisher 
Model 320 pH meter. 
Enzyme stock. solutions were prepared by centrifugation of the 
enzymes from their ammonium sulfate suspensions and dialyzed four times 
with 10 volumes of buffer and a minimum of two hours between buffer 
changes. Protein concentrations of all enzyme stock solutions were de-
termined spectrophotometrically using absorptivities of 1.45 ml mg-1 cm-1 
at 280 nm for LDH, 0.973 ml mg-1 cm-1 at 279 nm for GDH, and using 
absorptivities determined at 260 nm and 280 nm by Dandliker and Fox (25) 
for G3PD. GDH stock solutions were prepared in benzene-free phosphate 
buffer and purposely maintained at> 10 mg enzyme/ml during preparation 
to minimize the effects of diluting the benzene in the phosphate buffers 
to which it was subsequently transferred (15). Enzyme and reagent stock 
solutions used in light-scattering measurements were filtered through 
0.45µ pore-size Millipore MF filters, obtained from the Millipore Cor-
poration, Bedford, Massachusetts. GDH was treated with charcoal to 
remove bound nucleotides and centrifuged, then dialyzed and filtered 
prior to determining protein concentrations. Solutions of substrates 
and coenzymes at greater than final concentration were prepared from re-
agent stock solutions and filtered. The desired amount of this solution 
was then transferred into a light.,-scattering cell and diluted to the 
final concentration by addition of filte~.ed enzyme. Mixing of the light-
scattering solution was achieved by gently inverting the light~scattering 
cell. All glassware used in light-scattering measurements, including 
pipets and light-scattering cells, were rinsed with dust-free glass-
distilled water prior to each use. 
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Kinetic Measurements 
Enzymic activity in these studies was determined sp'ectrophotometri-
cally by measuring the rate of production or disappearance of NADH at 
340 nm. Enzyme specific activity is defined as the amount (µmoles) of 
product produced per unit time (minute) divided by the quantity of 
enzyme (mg) used to catalyze the reaction. 
All measurements of LDH and G3PD activity, as well as measurements 
of GDH activity at protein concentrations..$... 0.5 µg/ml were performed 
with a Coleman 124 ultraviolet-visible spectrophotometer equipped with 
a Coleman 165 recorder and Coleman No. 801 scale expander. Reaction 
rates were determined by measuring the slope of a tangent drawn to the 
most linear portion of the initial velocity trace. All enzy,,"' Ltu .. l\. 
solutions were routinely assayed prior to and at the end of ea~h ex-
periment, Standard assay conditions for the enzymes studied are given 
in Table I. 
Effects of the pyruvate-NAD-enzyme dead-end complex on initial 
velocity were measured by incubating LDH with pyruvate, NAD, and buffer 
in the cuvet prior to initiating the reaction with lactate. Other 
kinetic measurements, however, were started by addition of a small 
volume (0.01 - 0.05 mls) of enzyme stock solution as the last reagent, 
Stock GJPD solutions were maintained at concentrations .2:. 10 mg enzyme/ml 
because of the tendency of the enzyme to dissociate into monomers and 
denature upon dilution (26). Fresh serial dilutions of enzyme stock 
solution were used to initiate each reaction. Final enzyme concentra-
tions ranged from 0.05 µg/ml to 0.20 µg/ml in the reaction. Measurement 
of GDH specific activities at concentrations greater than 0.5 µg/ml 
were made with a Durrum-Gibson Stopped-Flow Spectrophotometer, made by 
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the Durrum Instrument Company, Palo Alto, California, using a 0.234 cm 
path length cell. Instrument calibrations have been previously des-
cribed (20), Reaction velocity traces were monitored on a Tektronix 
type 564 storage oscilloscope •. Data were permanently recorded by photo-
graphing storec;l oscilloscope traces using the projected graticule Tek-
tronix No. 100. Solutions to be placed in a specified drive syringe of 
the stopped-flow were pre-mixed in a beaker, then loaded into the drive 
syringe, The solutions.were prepared so that one drive syringe contain-
ed buffer, enzyme, nucleotide coenzyme and one substrate, while the 
other drive syringe contained buffer, enzyme, nucleotide coenzyme and 
the second substrate, 
Product concentrations were calculated from the stopped-flow records 
by application of-Beer's law with voltages assumed proportional to 
transmittances. Specific activities--were calculated from the initial 
reaction velocities. 
Molecular Weight Determinations 
Apparent weight-,.average molecular weights of GDH were determined 
from light-scattering measurements with a Brice-Phoenix Model 2000 
instrument and digital galvanometer (Phoenix Model DMR-200), Solutions 
were at room temperature (about 25° in an air-conditioned room). 
Cylindrical (C-105), micro (T-108) and 24x24 mm rectangular (T-104) 
cells were used. The primary data are galvanometer deflections, Ge, 
obtained with the detector at an angle e from the incident beam. Read-
ings were taken 5 seconds after opening the shutter in the sequence 
e = 0, 45, 58, 69, 80, 90, 100, 111, 122, and 135° for five cycles of 
this sequence. Average Ge values were corrected for a small dark 
current deflection and used to calculate Kc/Re at each e from 
= 
4.80xlo-9 x 0.918 
r 
a('r .. ) 
f (0)c x 1 
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(3-1) 
In this equation, f(0) = (1 + cos 2 0)/sin e, c is protein concentration 
in mg/ml, Fis the product of transmittances of filters used ate= O, 
~ denotes difference between solution and buffer values and a and(!..) 
r"' 
are constants determined by the user, Values obtained in this study 
are a = 0, 052, and er ) • 1. 60 or 2, 06 for the cylindrical and micro-
- r"' 
cells, respectively, The numerical factors in equation 3-1 are a com-
bination of constants, including the refractive i d O an f n ex increment~, o 
. dC 
the macromolecule in the solvent used. A value 
d . 
of a:= 0.195 ml/mg fer 
GDH in phosphate buffers was used (27). Some of the other constants in 
Equatibn 3-1 vary from one individual instrument to another and with 
different.cell types, The specific data, therefore, supplied with each 
instFument and opal glass reference standard need to be used in the more 
general equations described in the Operations Manual, in order to obtain 
correct numerical factors in Equation 3-1. Measurements made at 90°' 
only in the micro-cell to conserve ~nzyme utilized a simpler form of the 
above equation, 
KC = 
R90 
9 4.80x10- c. 
r 
a(r .. ) 
x 1 
G 
/j.F-2..Q.) Go 
(3-2) 
Molecular weights were determined from Equations 3~1 and 3-2 by the 
fundamental relation, 
KC 
R 
= 
1 [l+k R 2 s;tn2 G 
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described in the,Appendix. When the cylindrical cell was used permitting 
measurements at all angles, Kc/Re was plotted against sin2 (;) to give 
the weight average molecular weight as the reciprocal of the intercept 
ate= o. 0 When measurements.were made in the micro-cell at 90 only, 
the change in Kc/Re from 90 to o0 determined from previous measurements 
was substracted from Kc/R90 to give the intercept value. 
C}W>TER IV 
RESULTS AND DISCUSSION 
LDH 
Figure'l sunnnarizes initial velocity of lactate oxidation as.a 
function of pyruvate concentration. Bovine heart and rabbit muscle 
enzymes are compared. The two lactate concentrations used for these 
measurements correspond to levels.measured from exhaustively exercised 
and resting muscle, respectively (28), Table II sunnnarizes literature 
values of LDH isozyme and substrate concent;ratipn in the spec:!.fied 
tissues. These conqitions are most pertinent to this work, as the major-
ity of lactate oxidation occurs in liver.and heart, 
It is reasonal;,le t;o invoke formation of the ternary dead-end complex 
of pyruvate-NAD-enzyme to understand the _data presented in Figure 1 be-
cause half lives, t~, for complex formation under these conditions are 
on the order of a few seconds (29). In addition, LDH is continuously 
incubated with NAD and pyruvate in vivo, therefore, considerable ternary 
complex formation could be expected to occur~ 
Figure 1 indicates that with normal cellular levels of lactate in 
heart (<1.5 mM) but-no pyruvate, the heart isozyme is considerably more. 
efficient in lactate oxidation than t~e muscle isozyme as a consequence 
of its lower K for lactate (9 mM vs. 25 mM) (30), However, extensive m . 
inhibition by pyruvate develops with the.heart isozyme,at physiological 
levels of pyruvate and little-advantage of one isozynie over another can 
20 
Figure 1. Pyruvate Inhibition of Lactate Oxidation, Pyruvate concen-
trations are near physiological levels (6). The rate of 
NADH production was followed at 340 nm with 1 mM NAD and 
0.2-0.4 µg LDH/ml.' LDH-1 and LDH-5 are represented as 
( ()) and (/:::::.),for 0.15 mM (shaded symbols) and 20 mM 
(unshaded symbols) lactate, respectively. 
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100 
80 
LDH 
SPECIFIC 
60 
ACTIVITY 
Units 
mg 
40 
20 
0.2 0.4 0.6 0.8 
PYRUVATE, mM 
b Rat Heart 
Rat Skeletal 
Musclee 
Canine Skeletal 
Musclee 
Resting 
Ischemic and 
exhaustively 
exercised 
TABLE II 
LDH ENZYME AND SUBSTRATE 
LEVELS IN TISSUES 
Concentrations in 
mM and (nmoles/g 
of ·dry tissue)a 
Pyruvate Lactate 
0.05 
(130) 
0.33 
0.80 
0.27c 
(700) 
0.87 
(2,300) d 
1.5 
20 
23 
mg/ml a 
LDH-1 LDH-5 
0.33 0.0055 
0.0073 0.24 
Rat Liverf 0.50 (1.5)g 
(1,250) 
es sen- predominantly 
tially LDH-5 
none 
Rat 
Renal Medula 0.105 0.088 
aWuntch, Vesell, and Chen (1970) Science 167, 63-65. 
bwilliamson, J. R. (1965) J. Biol. Chem. 240, 2308-2321. 
Cnormalized to control 
d10 mM acetate infusion 
evesell, and. Pool (1966) Proc. Nat. Acad. Sc:i,., U.S . .21., 756-762. 
fwilliamson, J. R. (1966) Biochero. J, 101, llc; Exton, and Park 
(1969) J, Biol. Chem. 244, 1424~1433.~ 
gEstimation 
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be discerned, No evidence was obtained in these or other measurements 
that lactate dissociates th~ dead-end complex and hence abolishes pyru-
vate inhibition, as Kaplan (4) has described for cQicken heart LDH (29), 
On the other hand, a small reduction in heart .pyruvate.concentrations 
would cause.a large increase in lactate utilization, in contrast to the 
results with muscle isozyme. T~us, our observations are only partially 
in agreement with Kaplan's (4) latest views; they agree ·in demonstrating 
a potential advantage.of the heart isozyme in heart at·low pyruvate 
concentrations, but disagree in that we observe considerable inhibit.ion 
of the enzyme.at pyruvate concentrations at, or near those estimated 
to exist in heart tissue (Table II), Uncertainties from these measure-
ments result from our ignorance·of.pyruvate concentrations and distribu-
tions within cells. Everse and Kaplan (4) attempted to measure the 
extent Qf LDH dead-end complex formation in chicken heart and brea,st 
muscle. They measured LDH activity in these tissue·s after dilution of 
the cellular contents by homogenization with three volumes of buffer per 
gram of tissue. Since a steady increase in activity was observed in the. 
heart homogenates (but not breast muscle) with a ·time dependence quali-
tatively similar to rates of dissociation of enzyme.dead-end complex 
(t~ ~ 30 minutes), they conclude that an extensive fraction of LDH 
exists in the dead-end complex in heart. We _have not been able to re-
produce these observations, however. Furthermore, if appreciable dead-
end complex does exist, our measurements, in contrast to Kaplan's, 
suggest tha.t lac.tate oxidat_ion and pyruvate reduct:i,on would be equally 
inhibited, 
The conclusion of Wuntch.et al. (6) that pyruvate inhibition of LDH 
is not ~hysiologically significant may be valid; however, we do not 
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agree with their results because tl)e measurements of spec~fic activity 
which they report were made without pre-incubation of enzyme, pyruvate, 
and NAD, Under the conditions of enzyme concentration used by Wuntch, 
(10-6 M), the catalytic reaction would be over.before ternary complex 
formation could occur, since·at tl)is enzyme concentration, t~ for com-
plex formation would be.approximately 20 minutes. Using the same con-
centration of NAD, the time required for complex formation would be even 
longer when large concentrations of enzyme are used (29), 
The· conclusions of Stambaugh and Post seem even more qoubtful to us 
because lactate concentrations are unlikely to exist above 20 mM even in 
exhaustively exercised skeletal muscle, and muscle LDH is much less in-
hibited by lactate than heart isozyme (28). For rat heart perfused with 
10 mM glucose, lactate concentrations of 0.3 mM were recorded which in-
creased to.only 0.9 mM after addition of 10 mM acetate to the perfusing 
solution (30). Thus, it is doul?tful that lactate concentrations would 
ever reach inhibiting concentrations in viyo, 
GDH 
Table III ;compares molecular weights of GDH in benzene-free phosphate 
buffer, in benzeneccontaining phosphate buffer, and in benzene-containing 
phosphate buffer with inhibitqry concentrations of coenzyme (0.8 mM 
NADH), 0.1 M NH4Cl, and 25 mM glutaric acid, Glutaric acid., a substrate 
analog was used instead of a~ketoglutarate because we did not wish to 
have NADH depleted by enzyme-catalyzed reaction during the .measurements. 
Examination of molecular weights obtained in presence of benzene and in-
hibitory levels of NADH indicate a 20% decrease in molecular weight. 
relative to values obtained in absence of NADH. This is in keeping with 
Solution 
Compositiona 
la 
la 
la 
lb 
lb 
lb 
lb 
lb 
2a 
2b 
TABLE III 
APPARENT MOiECULAR WEIGHTS (M ) OF GDH 
app 
Enzyme 
Concentration 
(mg/ml) 
0.20 
0.40 
1.0 
0.10 
0.20 
0.40 
0.4 
1.0 
0.4 
0.4 
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M b 
(xiBE6) 
0.88 
1.01 
1.21 
1.45 
1.31 
1. 72 
1.81 
1.65 
1.16 
2.32 
aNumbers denote solution composition; letters indicate the absence 
or presence of benzene, as follows: 
SYMBOL DESIGNATION 
1 
2 
a 
b 
0.05 M potassium phosphate, pH 7.5 containing 0.2 M NaCl, 
0.1 mM EDTA, 0.6 mM NADH, 0.1 M NH4cl, 25 mM glutaric acid, 
0.05 M potassium phosphate, pH 7.5 containing 0.2 M NaCl, 
0.1 mM EDTA. 
no benzene 
Solution is at least 90% saturated with benzene. 
bThe estimated precision in Mapp is 0.1 x Mapp• 
data obtained in absence of benzene from our lab and Frieden's (32). 
These.values are also in good agreement with those of Reisler and 
Eisenberg (15) although Mapp in benzene solutions are a little lower, 
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Figure 2 summarizes inhibition of NADH oxidation by NADH and a-
ketoglutarate in benzene-free and benzene~containing systems at dilute 
enzyme·· concentration ~ 0. 5 µg/ml). Benzene does not·. alter the. activi-
ties of GDH which are maximal at 0.15 mM NADHand 5 mM a-,ketoglutarate 
and approximately 75% inhibition of activity occurs at 0.8 mM NADH and 
25 mM a.-KG. 
Figure-3 summarizes release of inhibition by NADH and increase in 
molecular weight of GDH as a functiqn of enzyme concentration. In the 
presence of benzene, association of enzyme subunits occurs to a much 
greater extent; how~ver, the presence of benzene has littie or no effect. 
on the spe~ific activity of GDH and the,loss.of enzyme inhibitiop occurs 
over.the same concentration range (0.1 - 0.4 mg/ml) in the presence or 
absence ·of benzen.e .. Although molecular weights obtained in the pres-
ence of benzene are somewhat erratic (Figure 3), additional data (Table 
III) substantiates our observations that benzene significantly enhances 
the extent of subunit association in the concentration range where the 
kinetic transition occurs (0.2 - 0.4 mg/ml). Thus, release of NADH 
inhibition with increasing enzyme concentration occurs independently of 
the protein associ.;1.tion-dissociation equilibrium. The inability to 
demonstrate inhibition by incubation of high concentrations of GDH with 
substrates and products prior to initiation of enzymic reaction indicates 
that high NADH concentrations promote a transition in.a central enzyme 
complex which is only present transiently during the enzymic reaction. 
Figure 2. NADH Inhibition of Dilute GDH in Presence and Absence of 
Benzene.· The rate of NADH disappearance was monitored at 
340 nm, with 0.1 M NH4Gl., 5 mM a-KG (unshaded symbols), 
25 mM a-:-KG (shaded symbols) , and O. 5 µg GDH/ml. Measure-
ments were performed in benzene-free ( ()) and benzene-
containing (~)phosphate buffers. 
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0.80 
Figure.3. Specific Activity and Molecular Weight of GDH as a Function 
of Concentration in Benzene-Free and Benzene-Containing 
Buffer. Disappearance of NADH was monitored at 340 nm with 
0.6 mM NADH, 0.1 M NH4Cl, and 25 mM a-KG. Specific activ-
ity 0) and molecular weight (A) data are shown for benzene-
free (open symbols) and benzene-containing (shaded symbols) 
phosphate buffers. Reasonable theoretical smooth curves 
are drawn for specific activity(---) and molecular weight 
data (-. -. ) . 
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G3PD 
Orsi and Cleland (17) have concluded that substrate oxidation at 
pH 8.6, catalyzed by rabbit muscle.G3PD proceeds by an.ordered ter-bi 
mechanism in which NADH cannot disociate from enzyme-product complexes 
until after release of the acyl product. This view conflicts with re-
sults from our lab at:pH 7.0 under conditions.where little deacylation 
occurs (20), Trentham (18) has shown that the .rate.of deaCylation in-
creases with pH until it exceeds the NADH dissociation rate constant 
at pH 8.0 and above.· If this occurs with the rabbit muscle enzyme, 
release of products from the enzyme could be random at low pH with the 
sequence, acyl phosphate, NADH becoming predominant near and above pH 
8.0. 
Under steady-state conditions, a random mechanism may be distin-
guished from an ordered mechanism by studies of product.inhibition of 
the reaction initial velocity. Prior to these studies, initial velocity 
measurements were made to determine optimal concentrations of all sub-
strates. Results of initial velocity measurements at pH 6.0 are summar-
ized for both enzyme preparations in Table IV. Discrepancies in optimal 
concentrations of substrates for the two enzyme preparations may be due 
in part to the difficulty of obt~ining reproducible initi~l velocities 
at pH 6.0. At pH 6.0, enzyme·turnover is very slow and this is reflec-
ted in the initial veloc:1,tie~ obtained, Wi~h both enzyme preparations, 
double reciprocal plots reveal product inhibition by NADH to be competi-
tive with NAD, (Figure 4a). This inhibition pattern alone.is consistent 
with either a random or an ordered mechanism of addition and release of 
substrates and products from the enzyme.· The fact, however, that 1,3-
diphosphoglycerate is also a c9mpetitive product inhibitor of NAD 
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TABLE; IV· 
OPTIMAL G3PD SUBST:tlA,TE CONCENTRATIONS AT:6.0 
Enzyme· 
Preparation NAD D-G3P Na2HA.s04 
Ferdinand 
Preparation 1.0 mM 4.0 mM 50 mM. 
Boehringer. 
Preparation 1.0 mM 1.0 mM 150 mM 
Figure 4a. Product Inhibition of G3PD Initial Velocity: NADH vs. NAD. 
NADH product inhibition of G3PD with NAD as variable sub-
strate was monitored at 340 nm with 5 mM D-G3P, 125 mM 
Na2HAs04 and O. 05-0. 2 µg G3PD/mL NADH ccmcentrations 
are designated as: O, ( () ); 0.01 mM, ( []);and 0.02 
mM, ( 6. ) . Measurements were performed in O. 05 M imida-
zole, pH 6.0, containing 0.1 M KCl, 1 mM EDTA, 1 mM DTT. 
0.60 
0.50 
0.40 
0.30 
Mxl03 -l 
min 
0.20 
0.10 
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(Figure 4b) is compatible with only the random.mechanism,· 
Similar product.inhibition st~dies were planned at pH 8.6, but 
initial velocity measurements revealed activation and inhibition ranges 
for arsenate which we would prefer to avoid in order not to introduce 
possible artifacts in our subsequent measurements. To avoid these com-
plications, product inhibition studies were planned on the reverse 
reaction in. the absence· of .. arsenate, Time was· not .. available, however, 
for me to complete these measurements, 
Spivey and Blanton (33) have·recently completed the necessary 
steady-state measurements of the reduction of 1,3-diphosphoglycerate at 
pH 8,6 and 7,0, It .is possible to report, tqerefore, that the results 
indicate tqat the steady-state mechantsm of G3PD enzyme changes from 
random to ordered as pH is increased to 8.6. The patterns observed and 
expected for these mechanisms are summarized in Table V. Both mechanisms 
include the dead-end complex of enzyme-NADH-glyceraldehyde-3-phosphate 
as demonstrated at pH 8.6 (17) and generally expected for rapid equil-
ibrium random patterns (34). 
We would caution, however, against the assumption that the G3PD 
mechanism is a purely sequential one. Good evidence exists for the· 
additional.sequence.in which NAD recombines with acyl-enzyme immediately 
after release of NADH and prior to release of the acyl group from the 
enzyme complex (18). This alternative sequence should be preferred at 
high NAD concentrations. With very low substrate concentrations, the 
enzymatic mechanism is apparently still more complex. Under these 
conditions, differing extents of substrate binding and catalytic activi-
ties may occur at each enzyme subunit with very complex interactions. 
among them, depending on the.degrees of saturation of each subunit with 
Figure 4b, Product Inhibition of G3PD Initial Velocity: 1,3-DPG vs. 
NAD, 1,3-DPGproduct inhibition of G3PD with NAD as 
variable substrate was followed at 340 nm, with 1 mM D-
G3P, 50 mM Na2HAs04 and O, 4 µg G3PD/ml. · 1, 3-DPG concen-
trat:tons are aesignated as: 0, ( 0 ) ; 0 .123 mM, ( 6. ) ; 
0, 307 mM, ( D ) , Measurements were performed. in O. 05 M 
imidazole, pH 6,0, containing 0.1 M KC!, 1 mM EDTA, and 
1 mM D~T. 
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Var 
Sub 
NADH 
NADH 
NAD 
NAD 
Prod· 
Inh 
NAD 
G3P 
DPG 
NADH 
TMLE V 
EXRE,C'l'ED AND OBSERVED STE4\l)Y-STATE PATTE.RNS 
FOR.RABBIT MUSCLE GLYCERA:r.,DEHYDE-3-
PHOSPHl\TE DEHYDROGENASEa 
EXPECTED OBSERVED 
Sat Rand Ord 
8.6b 7.0b $ub 
None. c c c C. 
or DPG 
None NC· UC UC c 
or DPG c UC 
Aso4+ 
G3P c UC 
As04+ 
G3P c c 
6.oc 
c 
c 
a Abbreviations:. Var Sub, Variable substrate; Prod Inh, Product 
Inhibitor; Sat Sub, Saturating substrate; Rand, Random; Ord, 
ordered. 
bData from Spivey and Blanton (33). 
cData from this thesis. 
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substrates and products (35). A general steady-state me~hantsm explain-
ing data under all of these conditions has not been proposed as yet. We 
do feel confident, howevert in having demonstrated that a shift with pH 
in preferred catalytic pathways does occur with G3PD near pH 8.0. Al-
though this shift could.permit·dissociatio~ of NADH from the enzyme 
prior to.the acyl gr9up (as in a random mechanism), possible complexities 
of the;real mechanism prevent us from considering thi~ NAD~ dissociation 
as proven by t~e st~ady-state data in this thesis. 
CHAPTER V 
SUMMARY 
Only. recently has the significance of the .. occurrence in vivo of 
many enzymes.at substrate·concentration been recognized. Enzymes at 
such concentrations would be subject to increased protein-protein inter-
actions and may exhibit ligand binding and kinetic constants different 
from those of dilute e~zymes assayed under conventional conditions in 
vitro. Thus, enzyme regulatory properties determined at dilute.enzyme 
concentrations .. in vitro may not reflect metabolic situations in vivo. 
The measurem.ents reported in this thesis are parts of studies in our 
lab to characterize enzyme kinetic and regulatory properties at physio-
logical enzyme concentrations.· 
LDH heart isozyme is more efficient in lactate oxidation than muscle 
isozyme, with physiological lactate levels in heart (< 1.5 mM), because 
of its lower~ for lactate (9 mM vs. 25 mM). However, use of physio-
logical pyruvate concentrations results in extensive pyruvate inhibition 
of heart.enzyme, and little advantage of one isozyme over the other can 
be discerned. No evidence was obtained that lactate abolishes pyruvate 
inhibition by dissociating the ternary pyruvate-NAD-enzymecomplex. On 
the other hand, a small reduction in heart pyruvate concentration would 
result in a large increase in lactate oxidation. 
Saturation of buffer with benzene or toluene leading to enhanced 
enzyme as~ociation provides a method for characterization of GDH kinetic 
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properties at differertt states of association. Substrate inhibitions 
of GDH by NADH and a-KG are unaltered by addition of benzene and re-
sulting increased association of enzyme. Maximal activity occurs at 
0.15 mM NADH and 5 mM a~KG, and approximately 75% inhibition occurs at 
0.8 mM NADH, and 25 mM a-KG. It has not been possible tq restore.NADH 
and GDP inhibitions of concentrated GDH by any possible combination of. 
incubatiqns of enzyme,.substrat~s, and products which might.form dead-
end complexes. Results with enzymes whose association was enhanced in 
benzene-containing buffers, therefore·demonstrated that·the release of 
substrate inhibition by NADH and a-KG when GDH is concentrated to 0.75 
mg/ml and above, ie due to a hysteretic (slow) transi.tion of an enzyme 
central complex, and not.due to increased enzyme association. Thus, 
with 0.8 mM NADH and 25 mM a-KG, one observes only the.inhibited reaction 
with transformed enzyme when GDH concentration< 0.5 µg/ml, However, 
when GDH is concentrated to approximately 1 mg/ml, only the uninhibited 
rate with untransformed enzyme·is observed, because NADH is depleted by 
the reaction before.the inhibitory complex can form in significant con-
centraticms, Molecular weights obtained, in the ·presence· of benzene 
agree.with those reported in the literature. 
A st~dy of concentrated G3PD at pH 6.0 in our lab has shown that 
NADH can be released from acylated or unacylated enzyme, and in the. 
absence of acyl acceptor during G3P oxidation. Competitive inhibitions 
of G3P oxidation by NADH and 1,3-DPG at dilute(< 0.2 µg enzyme/ml) 
enzyme.concentrations supp1;>rt a random mechanism at,pll 6.0. Spivey and 
Blanton completed measurements of 1,3-DPG reduction and found product 
inhibitions by NAD and G3P to be.non-competitive. We have concluded 
that th~ o:rderecl mechanism at.pH 8.6 is a special case of more general 
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random mechanism, and that the predominant pathway of addition and re-
lease of substrates and products from the enzyme shifts as pH is in-
creased. 
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APPENDIX 
An excellent treatment of light scattering theory is presented by 
Tanford (36), A brief summary and interpretation of the final working 
equations is presented here to facilit~te an evaluation of our.results. 
The intensity of light i 0 scattered from a macromolecular solution 
at an angle e relative to the incident beam is given by 
= KI0 (1 + cos2 0) c 
r2 
(A-,.1) 
for macromolecules whose size in any direction is less than 1/20 of the 
wavelength.of the incident light (~ 200 i for the 436 nm Hg line radia-
tion used). In Equatfon (A-1), I 0 is th~ intensity of the incident 
beam, K is known.constant.of the system, c is the macromolecular concen-
tration in,g/ml, r is the c9nstant distance between sample and detector, 
and Mapp is the-apparent molecular weight. Thus, ie is symmetrical 
about e = 90°. It is convenient to express Equation (A~l) as 
(A-2) 
KC. 1 
Re = Mapp 
utilizing the definition of Rayleigh's ratio, 
(A-3) 
1 + cos2e 
a constant independent of e. Experimental measurement of Re and calcu-
lation of Kc/Re are described.under MATERIAis AND EXPERIMENTAL PROCEDURES, 
p. 12. 
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Equation (A-2), when applied to an associating protomer system or 
heterogeneous polymer will necessc;lrily give the weight average molecular 
weight, 
(A-4) 
where c = Eci is the total weight concentratton of the:macromolecules 
in g/ml and the.subscripts refer to values of the.individuc;tl polymers 
with i =.1, 2, 3 •.• protomer.or monomer units (36). 
For macromolecules larger than 0.05'-, however, destructive inter-
ference.occurs fo+ all.scattering angles except ate= o, such that 
scattered intensities, i~ are requced below those.expected in the ab-
sence of destructive interference, i 8 • · For particles between 0.05 and 
0.5A, the equation 
(A-5) 
i 2· 2(~) e = 1 + kRG sin 2 
°Ie" 
is sufficiently accurate where k is a known constant and RG is the radius 
of gyration of the.parttcles. Consequetttly, Equation (A-2) becomes 
KC ::: 
R' e 
1 
~ 
app 
(A-6) 
and a plot of KC vs. 
R' e 
sin2 C!) will give ~1~ at its intercept. 
Mapp 
The 
condition of. significant destructive interference in i 8 is easily de-
tected by the dissymetry in i 8 as required by the sin2 term in Equation 
(A-5). This disymmetry is very small for glutamate dehydrogenase sol-
utions (10). 
Although Re corresponds more directly to the experimentally mea-
.' sured value, ie, the tu.rbidi ty, , , is used in the older literature. For 
48 
Thus , ~ or He are 
R ' 
equivalent with K • 3H/(16 ~) (36, p. 288), They are often interconver-
ted in this way although the conversion is not.accurate in principle for 
high turbidity values. It.would be preferable to drop use of, altogeth-
er. For non-associating macromolecules, th~ apparent molecular weight, 
is related to the true molecular weight, M, through 
i 1 
-M---= M+ 
a.pp 
Be +. Cc2 + 
(A-7) 
where Band Care thevirial coefficients in the power-series expansion 
of solvent chemical potential. Thus, extrapolation of l to c = 0 gives 
Mapp 
1. In the case of glutamate dehydrogenase, changing extents of enzyme 
M 
association preclude extrapolation to zero conc~ntration. Independent 
measurements or estimates reveal that the virial coefficients and terms 
are small in our experiments (27); however, and M is a sufficient 
. . eyp 
approximation of the weight average molecular weight of glutamate de-
hydrogenase. · 
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